Related references
Note: Only part of the references are listed.Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
O. Vilhelmsson Timmermand et al.
EJNMMI RESEARCH (2016)
Intratherapeutic Biokinetic Measurements, Dosimetry Parameter Estimates, and Monitoring of Treatment Efficacy Using Cerenkov Luminescence Imaging in Preclinical Radionuclide Therapy
Oskar Vilhelmsson Timmermand et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
Jung Eun Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Contemporary approaches for imaging skeletal metastasis
David Ulmert et al.
BONE RESEARCH (2015)
Taxonomy of breast cancer based on normal cell phenotype predicts outcome
Sandro Santagata et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Clinical targeting of the TNF and TNFR superfamilies
Michael Croft et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection
Daniel L. J. Thorek et al.
THROMBOSIS AND HAEMOSTASIS (2013)
The Clinical Value of Diffusion-Weighted Imaging in Combination With T2-Weighted Imaging in Diagnosing Prostate Carcinoma: A Systematic Review and Meta-Analysis
Lian-Ming Wu et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone
Susan Evans-Axelsson et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen
David Ulmert et al.
CANCER DISCOVERY (2012)
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni et al.
CANCER CELL (2011)
VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
Wouter B. Nagengast et al.
CANCER RESEARCH (2011)
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Jessica L. L. Robinson et al.
EMBO JOURNAL (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Complications After Prostate Biopsy: Data From SEER-Medicare
Stacy Loeb et al.
JOURNAL OF UROLOGY (2011)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
Leo A. Niemeier et al.
MODERN PATHOLOGY (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
Qing-Bai She et al.
PLOS ONE (2008)
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues
Sami Kilpinen et al.
GENOME BIOLOGY (2008)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
MA Titus et al.
CLINICAL CANCER RESEARCH (2005)
Development of sensitive immunoassays for free and total human glandular kallikrein 2
V Väisänen et al.
CLINICAL CHEMISTRY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells
M Yoshida et al.
IMMUNITY (2004)
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
IK Mellinghoff et al.
CANCER CELL (2004)
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
K Ellwood-Yen et al.
CANCER CELL (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies
RJ Ober et al.
INTERNATIONAL IMMUNOLOGY (2001)
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans
M Firan et al.
INTERNATIONAL IMMUNOLOGY (2001)
Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines
A Magklara et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
